Larson Financial Group’s Astria Therapeutics ATXS Stock Holding History

Larson Financial Group’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7	Closed	-$92	–	3638
2025 Q4	$92	Buy	+7	New	+$84	﹤0.01%	3344

Larson Financial Group's ATXS Position: Q1 2026 in Review

Larson Financial Group sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 7 shares — an estimated $92 sold.

Larson Financial Group first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $92 in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Larson Financial Group reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Larson Financial Group sold 7 Astria Therapeutics shares in Q1 2026, an estimated $92.
Larson Financial Group first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
Larson Financial Group's Astria Therapeutics position peaked at $92 in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.